Parallel Advisors’s AnaptysBio ANAB Stock Holding History

Parallel Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.71K	Sell	55 -11	-17%	-$667	﹤0.01%	3332
2026 Q1	$3.66K	Buy	66 +11	+20%	+$592	﹤0.01%	3153
2025 Q4	$2.67K	Hold	55	–	–	﹤0.01%	3057
2025 Q3	$1.68K	Hold	55	–	–	﹤0.01%	3096
2025 Q2	$1.22K	Hold	55	–	–	﹤0.01%	3158
2025 Q1	$1.04K	Hold	55	–	–	﹤0.01%	3111
2024 Q4	$728	Hold	55	–	–	﹤0.01%	3165
2024 Q3	$1.84K	Hold	55	–	–	﹤0.01%	2912
2024 Q2	$1.38K	Hold	55	–	–	﹤0.01%	2889
2024 Q1	$1.24K	Hold	55	–	–	﹤0.01%	2903
2023 Q4	$1.18K	Sell	55 -93	-63%	-$1.6K	﹤0.01%	2907
2023 Q3	$2.66K	Buy	148 +97	+190%	+$1.85K	﹤0.01%	2729
2023 Q2	$1.04K	Buy	51 +9	+21%	+$182	﹤0.01%	2920
2023 Q1	$914	Sell	42 -6	-13%	-$146	﹤0.01%	2977
2022 Q4	$1.49K	Buy	48 +6	+14%	+$169	﹤0.01%	2792
2022 Q3	$1K	Sell	42 -10	-19%	-$234	﹤0.01%	2840
2022 Q2	$1K	Buy	52 +5	+11%	+$111	﹤0.01%	2693
2022 Q1	$1K	Buy	47 +5	+12%	+$151	﹤0.01%	2680
2021 Q4	$1K	Hold	42	–	–	﹤0.01%	2819
2021 Q3	$1K	Hold	42	–	–	﹤0.01%	2794
2021 Q2	$1K	Hold	42	–	–	﹤0.01%	2677
2021 Q1	$1K	Hold	42	–	–	﹤0.01%	2572
2020 Q4	$1K	Hold	42	–	–	﹤0.01%	2390
2020 Q3	$1K	Sell	42 -41	-49%	-$740	﹤0.01%	2399
2020 Q2	$1K	Buy	83 +31	+60%	+$567	﹤0.01%	2283
2020 Q1	$0	Sell	52 -23	-31%	-$349	﹤0.01%	2380
2019 Q4	$1K	Buy	+75	New	+$1.77K	﹤0.01%	2280

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Parallel Advisors's ANAB Position: Q2 2026 in Review

Parallel Advisors reduced its AnaptysBio (ANAB) stake by 17% in Q2 2026, selling an estimated $667 and leaving 55 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

Parallel Advisors first reported a position in ANAB in Q4 2019 and has held it in 27 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Parallel Advisors held 55 shares of AnaptysBio worth $3.71K as of Q2 2026.
Parallel Advisors sold 11 AnaptysBio shares in Q2 2026, an estimated $667.
AnaptysBio made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3332 holding.
Parallel Advisors first reported a position in AnaptysBio in Q4 2019 and has held it in 27 quarters since.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.